Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 456
Immune Disorders Drugs 193
Cardiovascular Drugs 157
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 111
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 96
Pharmaceuticals 95
Leukemia Drugs 80
Hematological Drugs 77
Liver and Kidney Disorders Drugs 75
Lymphoma Drugs 62
Diabetes Drugs 57
Dermatological Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Pharmaceutical Intermediates 34
Drug Delivery 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
HIV/AIDS Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Vaccines 8
Transdermal and Transmucosal Drug Delivery 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,403 Results (Page 82 of 121)
- Relevance
  Sort by

South & Central America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
220 Pages

From

€3066EUR$3,450USD£2,655GBP

Middle East & Africa Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
230 Pages
Africa, Middle East

From

€3066EUR$3,450USD£2,655GBP

Europe Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
253 Pages
Europe

From

€3066EUR$3,450USD£2,655GBP

North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
224 Pages
North America

From

€3066EUR$3,450USD£2,655GBP

Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030

 Report
January 2024
100 Pages
Global

From

€5288EUR$5,950USD£4,578GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Neuropathy Pain Treatment Market by Treatment Type (Complementary, Device, Drug), Route Of Administration (Injectable, Oral, Topical), Distribution Channel, End User - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3151EUR$3,545USD£2,728GBP

€3501EUR$3,939USD£3,031GBP

Eosinophilic Esophagitis - Market Insight, Epidemiology and Market Forecast - 2034

 Report
October 2024
169 Pages
Global

From

€7066EUR$7,950USD£6,117GBP

Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035

 Report
October 2021
145 Pages
Global

From

€4265EUR$4,799USD£3,693GBP

Sarcoidosis - Pipeline Insight, 2025

 Clinical Trials
April 2025
75 Pages
Global

From

€1333EUR$1,500USD£1,154GBP

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

 Clinical Trials
November 2022
80 Pages
Global

From

€1778EUR$2,000USD£1,539GBP

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: An Industry Landscape Analysis of Stakeholders, Technologies, Pipeline, Partnering and Financing

 Report
March 2022
553 Pages
Global

From

€2450EUR$2,953USD£2,195GBP

Cancer Biologics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
January 2025
182 Pages
Global

From

€3999EUR$4,500USD£3,463GBP

CD47 Targeting Therapeutics Market by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035

 Report
September 2021
178 Pages
Global

From

€4265EUR$4,799USD£3,693GBP

AI-based Drug Discovery Market: Distribution by Drug Discovery Steps, Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
April 2022
334 Pages
Global

From

€4265EUR$4,799USD£3,693GBP

Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics),Regional Outlook- Global Forecast up to 2030

 Report
January 2024
116 Pages
Global

From

€3999EUR$4,500USD£3,463GBP

Myeloproliferative Disorders (MPD) Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
115 Pages
Global

From

€4222EUR$4,750USD£3,655GBP

Multiple Sclerosis Market in US 2025-2029

 Report
December 2024
139 Pages
United States

From

€2222EUR$2,500USD£1,924GBP

Rare Disease Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4399EUR$4,949USD£3,808GBP

HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market 2024-2028

 Report
October 2023
164 Pages
Global

From

€2222EUR$2,500USD£1,924GBP

Sarcoma Drugs Market by Indication, Drugs, Sales Channel, End-User - Global Forecast 2025-2030

 Report
October 2024
184 Pages

From

€3151EUR$3,545USD£2,728GBP

€3501EUR$3,939USD£3,031GBP

2,403 Results (Page 82 of 121)
- 1
- 80
- 81
- 82
- 83
- 84

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.